Company / Return on Assets (ROA)
Akebia Therapeutics, Inc. Return on Assets (ROA) History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-1.4%
FY2025
5-year range
-53.2% / -1.4%
FY2021-FY2025
Trend
+95.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -53.2% in FY2021 to -1.4% in FY2025.
Based on SEC 10-K filings.
-1.4% in FY2025 with a 10-year CAGR of +7.8%.
Improved from -21.5% to -1.4% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +25.0pp
- 5-Year Change
- +20.9pp
- 10-Year Change
- +7.8pp
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 95.5% year-over-year.
- Lowest return on assets (roa) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1.4% | +95.5% |
| FY2024 | -31.4% | -46.4% |
| FY2023 | -21.5% | +18.8% |
| FY2022 | -26.5% | +50.3% |
| FY2021 | -53.2% | -138.7% |
| FY2020 | -22.3% | -133.4% |
| FY2019 | -9.6% | +29.9% |
| FY2018 | -13.6% | -47.9% |
| FY2015 | -9.2% | -24.8% |
| FY2014 | -7.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026